Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Haoxi Health TechnologyHAO -13.51%21 EBITDA Margin % is -19.24% as of Dec. 2025. GuruFocus rates HAO with a GF Score™ of 21/100. The stock has 5 warning signs investors should review. Among 1,009 Media - Diversified companies, Haoxi Health Technology ranks worse than 76.02% on this metric.
Haoxi Health Technology (NAS:HAO) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Haoxi Health Technology EBITDA Margin % Related Terms
Haoxi Health Technology EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HAO vs BAOS, DBMM, DRCT: EBITDA Margin % Comparison
For the Advertising Agencies subindustry, Haoxi Health Technology's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Haoxi Health Technology EBITDA Margin % vs Media - Diversified Industry
For the Media - Diversified industry and Communication Services sector, Haoxi Health Technology's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Haoxi Health Technology's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Haoxi Health Technology (HAO) has a EBITDA Margin % of -19.24% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Haoxi Health Technology and its competitors. According to the industry distribution chart, Haoxi Health Technology ranks #767 out of 1009 companies in the Media - Diversified industry, placing it in the top 76%.
Is Haoxi Health Technology's EBITDA Margin % too high?
Haoxi Health Technology's current EBITDA Margin % is -19.24%. Based on the distribution chart, Haoxi Health Technology ranks #767 out of 1009 companies in the Media - Diversified industry, which is in the bottom quartile relative to peers. Overall, Haoxi Health Technology has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Haoxi Health Technology's EBITDA Margin % compare to BAOS and DBMM?
According to the Media - Diversified industry distribution chart, Haoxi Health Technology ranks #767 out of 1009 companies for EBITDA Margin %. This places Haoxi Health Technology in the lower half of its industry. The industry median EBITDA Margin % is 8.21. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Media - Diversified company?
The median EBITDA Margin % among Media - Diversified companies is 8.21, based on 1,009 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Haoxi Health Technology and its competitors. For the Media - Diversified industry, the median EBITDA Margin % is 8.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Haoxi Health Technology's current EBITDA Margin % is -19.24%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Haoxi Health Technology stock overvalued right now?
Haoxi Health Technology (HAO) has a current EBITDA Margin % of -19.24%. The current EBITDA Margin % is -19.24%. Haoxi Health Technology's overall GF Score™ is 21/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Haoxi Health Technology (HAO), the current EBITDA Margin % is -19.24% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Haoxi Health Technology Ltd is an online marketing solution provider in China, with an advertiser client base mainly in the healthcare industry. The company offers services that include planning, producing, placing, and optimizing online ads especially online short video ads, to help its advertisers acquire, convert, and retain ultimate consumers on various online media platforms. It places advertisements on popular digital platforms such as Toutiao, Douyin, WeChat, and Sina Weibo through media partners. Revenue is generated by providing comprehensive online marketing solutions. The company's operations center on digital advertising via mainstream video and social media channels in the Chinese market.
21GF Score
Get the complete analysis for HAO
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HAO has been successfully added to your 
